Acadia Pharmaceuticals Inc

CHARLES SCHWAB INVESTMENT MANAGEMENT INC ACAD

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

1,172,317

Value ($000)

31,313

Weight

0.0%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	31,313	0.0%	1,172,317	12/31/2025
2025 Q3	11/10/2025	25,695	0.0%	1,204,088	9/30/2025
2025 Q2	8/12/2025	25,665	0.0%	1,189,861	6/30/2025
2025 Q1	9/15/2025	19,946	0.0%	1,200,839	3/31/2025
2024 Q4	2/6/2025	22,962	0.0%	1,251,332	12/31/2024
2024 Q3	11/12/2024	19,550	0.0%	1,271,135	9/30/2024
2024 Q2	8/12/2024	20,723	0.0%	1,275,279	6/30/2024
2024 Q1	5/9/2024	21,985	0.0%	1,189,043	3/31/2024
2023 Q4	2/6/2024	35,315	0.0%	1,127,907	12/31/2023
2023 Q3	11/8/2023	22,363	0.0%	1,073,093	9/30/2023
2023 Q2	8/10/2023	23,506	0.0%	981,452	6/30/2023
2023 Q1	5/12/2023	18,242	0.0%	969,294	3/31/2023
2022 Q4	2/13/2023	15,470	0.0%	971,754	12/31/2022
2022 Q3	11/14/2022	15,586	0.0%	952,674	9/30/2022
2022 Q2	8/15/2022	12,923	0.0%	917,161	6/30/2022
2022 Q1	5/13/2022	22,689	0.0%	936,774	3/31/2022
2021 Q4	2/11/2022	20,610	0.0%	883,001	12/31/2021
2021 Q3	11/16/2021	13,639	0.0%	821,102	9/30/2021
2021 Q2	8/16/2021	27,058	0.0%	1,109,369	6/30/2021
2021 Q1	5/17/2021	21,842	0.0%	846,563	3/31/2021
2020 Q4	2/16/2021	45,835	0.0%	857,370	12/31/2020
2020 Q3	11/13/2020	36,942	0.0%	895,547	9/30/2020
2020 Q2	8/20/2020	35,629	0.0%	735,065	6/30/2020
2020 Q1	5/15/2020	35,615	0.0%	842,958	3/31/2020
2019 Q4	2/7/2020	31,265	0.0%	730,823	12/31/2019
2014 Q2	7/30/2014	4,895	0.0%	216,662	6/30/2014
2014 Q1	4/29/2014	5,018	0.0%	206,238	3/31/2014
2013 Q4	2/14/2014	4,647	0.0%	185,924	12/31/2013